跳至主要内容
临床试验/NCT05862805
NCT05862805招募中1 期

The Role of Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), Tissue Factor Pathway Inhibitor (TFPI), and Endometrial Endothelial Cells in Uterine Hemostasis in Humans

Oregon Health and Science University2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年7月12日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
70
试验地点
2
主要终点
Total number of mRNA copies from HEEC culture of tPA

研究概览

简要总结

The purpose of the study is to learn more about the role of blood clotting factor proteins and cells in menstrual (period) bleeding. The investigators are hoping to identify differences in these proteins and cells in the menstrual blood of individuals with heavy periods compared to menstruating individuals who do not have heavy periods.

详细描述

The purpose of this study is to learn if human endometrial endothelial cells (HEECs) regulate human uterine hemostasis through the up and down-regulation of pro- and anti-coagulant factors in menstrual blood including PAI-1, factor XI (FXI)-PAI-1 complex, tPA, and TFPI.

This study will enroll participants with heavy menstrual bleeding (HMB) and participants without HMB. Coagulation factors will be measured in menstrual blood and mRNA for these factors will be quantified from cultured HEECS from endometrial biopsies and compared between groups.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Regularly menstruating participants between 18-45 years of age

排除标准

  • Pregnancy within 3 months of enrollment
  • Lactating at the time of enrollment
  • Hormonal contraceptive use or use of the copper intrauterine device (IUD)
  • Antifibrinolytic use
  • Inherited or acquired bleeding disorder or anticoagulant use
  • Known structural cause of HMB
  • Inability to complete PBACs
  • Unwilling to refrain from sexual intercourse for the two weeks prior to endometrial biopsy

结局指标

主要结局

Total number of mRNA copies from HEEC culture of tPA

时间窗: Enrollment to 60 days

The total number of mRNA copies of tPA in HEEC cultures from enrollment to 60 days.

Total number of mRNA copies from HEEC culture of PAI-1

时间窗: Enrollment to 60 days

The total number of mRNA copies of PAI-1 in HEEC cultures from enrollment to 60 days.

Total number of mRNA copies from HEEC culture of TFPI

时间窗: Enrollment to 60 days

The total number of mRNA copies of TFPI in HEEC cultures from enrollment to 60 days.

Change in the numerical score of Pictorial Blood Loss Assessment

时间窗: Enrollment to 60 days

The change in the Pictorial Blood Loss Assessment Charts (PBACs) from baseline to 60 days. Participants will be asked to tally the number of pads and tampons, the level of saturation of menstrual blood on the pads or tampons, and the number of clots. Scores greater than 100 are considered diagnostic of heavy menstrual bleeding.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bannowb

Principal Investigator

Oregon Health and Science University

研究点 (2)

Loading locations...

相似试验